Stocksigma LogoStocksigma Logo

Jagsonpal Pharmaceuticals Acquires Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores

Jagsonpal Pharmaceuticals executed a Business Transfer Agreement on 23rd Sep'26 to acquire the Wellness Portfolio of Group Pharmaceuticals via slump sale

Jagsonpal Pharmaceuticals Acquires Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores

Jagsonpal Pharmaceuticals Ltd · Press Release · 23 Sept 2026, 11:32 pm

Jagsonpal Pharmaceuticals Acquires Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores Jagsonpal Pharmaceuticals executed a Business Transfer Agreement on 23rd Sep'26 to acquire the Wellness Portfolio of Group Pharmaceuticals via slump sale. The target portfolio generated ₹24.6 crore turnover in FY'26 and strengthens Jagsonpal’s footprint in women’s healthcare. The transaction includes an initial cash consideration of ₹23.7 crore at closing, with performance-linked consideration of up to ₹23.0 crore tied to FY'28 sales, capping total payout at ₹46.7 crore. The acquisition requires no regulatory approvals and is slated for completion on or before 1st Nov'26.

Original exchange filing (PDF)

More announcements from Jagsonpal Pharmaceuticals Ltd

All Jagsonpal Pharmaceuticals Ltd announcements